Protalix BioTherapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
- Thursday, March 4, 2021, 7:04
- Finance
- Add a comment
CARMIEL, Israel, March 4, 2021 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…
About the Author
adminasapcorp has written 41302 stories on this site.